Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11128863 | 0.81 | MAPT (0.38) | AXLMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL80034 | 0.79 | AXL (0.38) | AXLMAPTALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL29160600 | 0.77 | ALDH1A1 (0.39) | AXLMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL239457 | 0.72 | PTGER4 (0.43) | AXLMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL21980637 | 0.72 | POLB (0.44) | MAPTALDH1A1MEN1KMT2APOLB | |
| SCHEMBL6960971 | 0.72 | CA1 (0.40) | AXLMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL7209297 | 0.72 | TSHR (0.39) | MAPTALDH1A1GAACA12CA1 | |
| SCHEMBL15231722 | 0.72 | ALDH1A1 (0.39) | ALDH1A1CA12CA1CA2CA4 | |
| SCHEMBL10736045 | 0.72 | GAA (0.32) | MAPTGAA | |
| SCHEMBL145182 | 0.72 | ALDH1A1 (0.39) | AXLMAPTALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114573805-B | Preparation method of high-barrier transparent flame-retardant copolymerized nylon | 浙江恒逸石化研究院有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-114874418-B | Conjugated polymer based on trifluoromethyl substituted quinoxaline, and preparation method and application thereof | 广东聚石科技研究有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-114874418-A | Conjugated polymer based on trifluoromethyl substituted quinoxaline and preparation method and application thereof | 广东聚石科技研究有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-108440417-B | 1- methyl thio phenyl benzimidazole and its derivative synthesizing process | 湘潭大学 | 2019-09-24 | — | — | CN | claimed |
| CN-108440417-A | 1- methyl thio phenyls benzimidazole and its derivative synthesizing process | 湘潭大学 | 2018-08-24 | — | — | CN | claimed |
| CN-114573805-B | Preparation method of high-barrier transparent flame-retardant copolymerized nylon | 浙江恒逸石化研究院有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-114874418-B | Conjugated polymer based on trifluoromethyl substituted quinoxaline, and preparation method and application thereof | 广东聚石科技研究有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-114573796-B | Tris (4-ethynylphenyl) amine conjugated microporous polymer, preparation method and application | 郑州轻工业大学 | 2023-08-04 | — | — | CN | disclosed |
| US-11446294-B2 | Non-platinum-based anti-cancer compounds for use in targeted chemotherapy | LU QING BIN (CA) | 2022-09-20 | — | — | US | disclosed |
| CN-114874418-A | Conjugated polymer based on trifluoromethyl substituted quinoxaline and preparation method and application thereof | 广东聚石科技研究有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-114573796-A | Tris (4-ethynylphenyl) amine conjugated microporous polymer, preparation method and application | 郑州轻工业大学 | 2022-06-03 | — | — | CN | disclosed |
| CN-114380700-A | Non-platinum based anti-cancer compounds for targeted chemotherapy | 卢庆彬 | 2022-04-22 | — | — | CN | disclosed |
| CN-102276799-B | Quinoxaline unit-containing fluorene copolymer, and preparation method and application thereof | OCEANS KING LIGHTING TECH CO | 2014-05-28 | — | — | CN | disclosed |
| US-20120101243-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | UNITED STATES DEPARTMENT OF ENERGY | 2012-04-26 | — | — | US | disclosed |
| US-8106393-B2 | Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-01-31 | — | — | US | disclosed |
| US-20120004384-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | UNITED STATES DEPARTMENT OF ENERGY | 2012-01-05 | — | — | US | disclosed |
| US-7919770-B2 | Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom | NORTH CAROLINA STATE UNIVERSITY (US) | 2011-04-05 | — | — | US | disclosed |
| CN-1891754-B | Novel organic polymer semiconductor, method for forming organic polymer semiconductor thin film and organic thin film transistor using the same | SAMSUNG ELECTRONICS CO LTD | 2011-03-09 | — | — | CN | disclosed |
| US-20110015388-A1 | Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom | UNITED STATES DEPARTMENT OF ENERGY | 2011-01-20 | — | — | US | disclosed |
| CN-1891754-A | Novel organic polymer semiconductor, method for forming organic polymer semiconductor thin film and organic thin film transistor using the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-01-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004384-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | PNMT, HNMT, COMT | AXL 724/4885MAPT 971/4885ALDH1A1 767/4885 |
| US-11446294-B2 | Non-platinum-based anti-cancer compounds for use in targeted chemotherapy | TOP2B, RB1, POLR2B | AXL 2587/4885MAPT 3743/4885ALDH1A1 849/4885 |
| US-20120101243-A1 | SUBSTITUTED BENZAZOLOPORPHYRAZINES FOR POLYMERIZATION AND SURFACE ATTACHMENT AND ARTICLES FORMED THEREFROM | PNMT, HNMT, COMT | AXL 724/4885MAPT 971/4885ALDH1A1 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.